- Ideas
- Markets
- Cryptocurrencies
- Currencies
- Stocks
- Earnings Calendar
- Stock Screener
- Large-Cap
- Top Gainers
- Top Losers
- Most Active
- Most Volatile
- Overbought
- Oversold
- All Time High
- All Time Low
- Sector & Industry
NOKIA OYJ ADR EACH REPR 1 ORD NPV, GENERAL ELECTRIC CO, ISHARES TRUST MSCI EMG MKTS ETF USD DIS, SPDR S&P500 ETF TRUST S&P 500 ETF USD DIS, ADVANCED MICRO DEVICES INC, FACEBOOK INC
- Indices
S&P 500, Nasdaq Composite, Dow 30, Nikkei 225, DAX Index, FTSE 100
- Futures
- Bonds
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
- CFDs
Gold, Brent Oil, Crude Oil, CFDs on Natural Gas, Palladium, Silver
- Scripts
- Oscillators
- Centered Oscillators
- Volatility
- Trend Analysis
- Volume
- Moving Average
- Exponential Moving Average (EMA)
- Weighted Moving Average (WMA)
- Simple Moving Average (SMA)
- Hull Moving Average (HMA)
- Kaufman's Adaptive Moving Average (KAMA)
- Smoothed Moving Average (SMMA)
- Variable Index Dynamic Average (VIDYA)
- Volume-weighted Moving Average (VWMA)
- Fractal Adaptive Moving Average (FRAMA)
- Double Exponential Moving Average (DEMA)
- Breadth Indicators
- Bill Williams Indicators
- Screener
- Shows
- Chart
- More
DECIPHERA PHARMACEUTICALS INC
NASDAQ
DCPH
Anbat
27 views
・
Once PA finds support after INSIDERS, sell some of their initial shares for a profit from $17.00, then it will be time to go long again. Patience Is Key!! IPO Lockup Expiration will be on 3/27/2028 (Tuesday) and TREND is bearish, stay on it until PA proves it has found a SUPPORT level.
Anbat
24 views
・
WALTHAM, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced the closing of its initial public offering of 7,500,000 shares of its common stock at a public offering price of $17.00 per share. The gross proceeds from the...
Financials
Profile
News
Stock Charts & Forex Charts